← Mechanisms of action
Borrelia burgdorferi
ORGANISMBorrelia burgdorferi (strain ATCC 35210 / B31 / CIP 102532 / DSM4680)
Drugs acting on this target (5)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| 2217ls | Antagonist | experimental | mAb | Borrelia burgdorferi antagonist |
| mrna-1975 | Immunity, active | experimental | Vaccine | Borrelia burgdorferi immunity, active |
| mrna-1982 | Immunity, active | experimental | Vaccine | Borrelia burgdorferi immunity, active |
| multivalent recombinant ospa lyme borreliosis vaccine | Immunity, active | experimental | Vaccine | Borrelia burgdorferi immunity, active |
| recombinant b. burgdorferi surface protein (outer-surface protein a; ospa) (LYMErix) | Immunity, active | withdrawn | Vaccine | Borrelia burgdorferi immunity, active |